International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 795-799 doi: 10.5281/zenodo.16901936
Original Article
A study to evaluate the clinical correlation between migraine and mood disorders
 ,
Published
Aug. 19, 2025
Abstract

Background: Migraine is a common neurological disorder often associated with psychiatric comorbidities, particularly mood disorders such as depression and anxiety. This study aims to evaluate the clinical correlation between migraine and mood disorders.

Methods: A prospective observational study was conducted on 84 patients diagnosed with migraine (based on ICHD-3 criteria). Participants were assessed for mood disorders using the Hamilton Depression Rating Scale (HDRS) and Hamilton Anxiety Rating Scale (HARS). Migraine severity, frequency, and disability were measured using the Migraine Disability Assessment (MIDAS) questionnaire. Statistical analysis was performed using Pearson’s correlation and chi-square tests.

Results: Among 84 participants (mean age 35.2 ± 9.4 years, 68% female), 52.4% (n=44) exhibited clinically significant depressive symptoms (HDRS ≥ 8), while 45.2% (n=38) had anxiety symptoms (HARS ≥ 10). A strong positive correlation was found between migraine frequency and depression severity (r = 0.62, p < 0.001). Patients with chronic migraine (≥15 headache days/month) had higher depression and anxiety scores compared to episodic migraine sufferers (p < 0.01).

Conclusion: This study demonstrates a significant correlation between migraine and mood disorders, suggesting that migraineurs are at higher risk of developing depression and anxiety. Early screening and integrated treatment approaches may improve clinical outcomes

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
838 Views
73 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved